Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Hikma Pharmaceuticals (HIK.L) has a market cap of $5.57 billion USD. According to our data, Hikma Pharmaceuticals is ranked No.2410 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $5.57 B |
-99.05%
|
| Dec 31, 2024 | $585.52 B |
15.93%
|
| Dec 29, 2023 | $505.05 B |
18.37%
|
| Dec 30, 2022 | $426.67 B |
-28.40%
|
| Dec 31, 2021 | $595.89 B |
-10.43%
|
| Dec 31, 2020 | $665.27 B |
28.87%
|
| Dec 31, 2019 | $516.24 B |
18.12%
|
| Dec 31, 2018 | $437.05 B |
54.10%
|
| Dec 29, 2017 | $283.62 B |
-38.99%
|
| Dec 30, 2016 | $464.85 B |
-16.83%
|
| Dec 31, 2015 | $558.92 B |
17.15%
|
| Dec 31, 2014 | $477.08 B |
65.83%
|
| Dec 31, 2013 | $287.70 B |
59.57%
|
| Dec 31, 2012 | $180.30 B |
24.23%
|
| Dec 30, 2011 | $145.13 B |
-22.63%
|
| Dec 31, 2010 | $187.58 B |
60.94%
|
| Dec 31, 2009 | $116.55 B |
47.64%
|
| Dec 31, 2008 | $78.94 B |
-25.40%
|
| Dec 31, 2007 | $105.82 B |
30.84%
|
| Dec 29, 2006 | $80.88 B |
-9.30%
|
| Dec 30, 2005 | $89.17 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
 Perrigo
PRGO
|
$3.42 B |
-0.000 M
|
Ireland
|
 Amneal Pharmaceuticals
AMRX
|
$3.34 B |
1.091 B
|
USA
|
 Viatris
VTRS
|
$8.93 B |
-0.000 M
|
USA
|
 Dr. Reddy's
RDY
|
$11.10 B |
0.000 M
|
India
|
| Market Cap | = | HIK.L Stock Price | * | HIK.L Shares Outstanding |
| = | $2,524.99 | * | 0.22 B | |
| = | $5.57 B |